New: NCI-funded clinical trial search
Mednet Logo
CommunityNeurology

Do you utilize neurofilament light chain to guide your treatment strategy for multiple sclerosis?

In light of the publication from Fernández et al., PMID 42623577.
1 Answer
Mednet Member
Mednet MemberInvited Expert
Neurology · Yale University School of Medicine
Answered on

I do not routinely use serum neurofilament light chain levels to guide treatment decisions. The vast majority of my patients with relapsing-remitting MS are already on high-efficacy therapy, so it would not change my DMT management. In patients with progressive disease, the NfL trend over time is on...

Join for free or sign in to see the full answer